SIRT1 regulates Mxd1 during malignant melanoma progression

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Malignant transformation in a murine melanoma model is linked to stress, reactive oxygen species, DNA damage, and epigenetic alterations.
• Sirtuin-1 (SIRT1), a chromatin modifier, is recruited to DNA breaks and influences epigenetic machinery.

Purpose of the Study:

• To investigate the role of SIRT1 in melanomagenesis within a murine melanoma model.
• To define the molecular mechanisms by which SIRT1 contributes to melanoma progression.

Main Methods:

• Murine melanoma model, DNA damage marker analysis (γH2AX), SIRT1 expression, histone modification analysis (H4K16ac).
• Chromatin immunoprecipitation sequencing (ChIP-seq) to identify SIRT1 targets, co-immunoprecipitation to assess protein complexes (SIRT1-DNMT3B).
• Gene silencing (Sirt1 stable silencing), gene expression analysis (mRNA), treatment with DNA methyltransferase (DNMT) inhibitor (5AzaCdR).

Main Results:

• Increased DNA damage marker γH2AX and SIRT1 expression, with decreased H4K16ac in melanocytes under stress (deadhesion).
• SIRT1 formed a complex with DNMT3B, identified as a target of both proteins, and Mxd1 was found downregulated in melanoma progression.
• Sirt1 silencing increased Mxd1 expression and downregulated MYC targets (Cdkn1a, Bcl2, Psen2), while DNMT inhibitor treatment reversed Mxd1 downregulation.

Conclusions:

• SIRT1 plays a novel role in stress-induced melanocyte malignant transformation associated with deadhesion.
• Mxd1 is a novel SIRT1 target gene, and SIRT1-mediated Mxd1 silencing contributes to melanoma progression by increasing MYC oncogene activity.